-
Fluorescein Tyramide for Neurocircuit Assays
2026-09-15
Fluorescein Tyramide can translate subtle oxytocin-related changes in neurocircuit tissue into measurable fluorescent signals. This guide connects a recent early-life adversity study with practical decisions for IHC, ISH, and flow cytometry assay design.
-
Epoxomicin A2606 for Reliable Cell Assays
2026-09-15
Epoxomicin (SKU A2606) provides a mechanistically defined way to perturb 20S proteasome activity in cell viability, proliferation, and protein degradation experiments. This guide addresses assay design, DMSO stock preparation, data interpretation, and supplier selection using the documented 4 nM chymotrypsin-like activity IC50 and practical formulation guidance.
-
Protein A/G Magnetic Co-IP/IP Kit in Translation
2026-09-14
A mechanistic and strategic guide to using co-immunoprecipitation for translational research, anchored in PML–HIF1AN signaling during BMSC osteogenic differentiation. The article explains how magnetic bead workflows can strengthen protein-protein interaction analysis, improve sample integrity, and help convert mechanistic observations into reproducible research programs.
-
FKBP9, ER Stress, and Glioblastoma Progression
2026-09-14
Xu et al. identify FKBP9 as an oncogenic regulator in glioblastoma and connect its activity to ASK1–p38MAPK signaling, the IRE1α–XBP1 unfolded protein response, and resistance to ER stress. The work provides a mechanistic framework for studying how ER proteostasis supports tumor growth and suggests experimental strategies for testing stress-sensitization mechanisms.
-
MLN2238: From Proteasome Stress to Translation
2026-09-13
A mechanistic and strategic guide to using MLN2238 as a reversible proteasome β5 subunit inhibitor in oncology, proteotoxic-stress, multiple myeloma, lymphoma, and resistance-focused research.
-
Cy5 maleimide (non-sulfonated): Practical Guide
2026-09-12
Cy5 maleimide (non-sulfonated) is a mono-reactive fluorescent reagent for labeling accessible thiol groups, especially cysteine residues, on peptides and proteins. It is appropriate for controlled conjugation and fluorescence detection but requires an organic co-solvent because of its low aqueous solubility and is not a suitable choice when aqueous-only reagent handling or non-thiol labeling is required.
-
Mouse Tissue Lysis Kit K1038: Workflow Guide
2026-09-12
The Mouse Tissue Lysis Kit K1038 supports rapid digestion of mouse tail, toe, and ear tissue for direct PCR-based genotyping without a separate DNA extraction or purification step. It is intended for molecular biology research and assay development, not diagnostic, clinical, or medical testing.
-
ML365: TASK1 Workflows and Research Applications
2026-09-11
ML365 combines nanomolar TASK1 inhibition with a practical path from ion-channel assays to neuroinflammation studies. Its orthogonal assay performance, channel selectivity, and reported activity in an aged-mouse postoperative model make it useful for target validation, while mGluR5 activity and platform-dependent potency require disciplined controls.
-
Bortezomib (PS-341): Practical Workflow Guide
2026-09-11
Bortezomib (PS-341) provides reversible 20S proteasome inhibition for controlled cell-based studies of proteasome-regulated cellular processes, viability, and apoptosis. Use the dossier values as model-specific reference points rather than universal doses, and do not transfer the reported xenograft dose directly to new animal or clinical protocols.
-
CMA Decline and Age-Related Skeletal Muscle Myopathy
2026-09-10
This study establishes chaperone-mediated autophagy (CMA) as an active regulator of skeletal muscle homeostasis rather than a passive lysosomal pathway. By combining reporter mice, muscle-specific Lamp2a deletion, proteomics, human muscle analysis, and genetic rescue, the authors connect impaired CMA to SERCA turnover, calcium dysregulation, and progressive myopathy.
-
Diuron Workflows for Plant and Toxicology Research
2026-09-10
Diuron enables controlled studies of photosynthetic electron transport, herbicide persistence, and emerging renal toxicity. This practical guide connects plant assays with HK-2 cell workflows, emphasizing solvent control, exposure design, and troubleshooting for reproducible mechanistic data.
-
Moxidectin: From Parasite Control to Assay Design
2026-09-09
Moxidectin is a macrocyclic lactone anthelmintic with an emerging role in polyene-based antifungal research. This article translates the 2024 Candida albicans findings into a practical, mechanism-aware framework for assay design while defining the limits of cross-domain interpretation.
-
Calpain Inhibitor I, ALLN: Practical Protocol Guide
2026-09-09
Calpain Inhibitor I, ALLN (SKU A2602) is a research reagent for experimentally modulating calpain I, calpain II, cathepsin B, and cathepsin L activity in apoptosis, inflammation, and ischemia-reperfusion workflows. It should be used as a mechanistic perturbation tool with appropriate vehicle, protease, and viability controls, not as a diagnostic, clinical, or calpain-exclusive reagent.
-
Exogenous NADH Enhances Aminoglycosides Against E. tarda
2026-09-08
The 2024 study shows that exogenous NADH can reprogram Edwardsiella tarda metabolism and strengthen neomycin-mediated bacterial killing, with ATP-linked energy metabolism emerging as a central feature. Its broader testing across antibiotic classes and resistant pathogens supports metabolic sensitization as a complementary strategy, although translation beyond the tested models remains to be established.
-
Glioblastoma Apoptotic Priming and BH3-Mimetic Therapy
2026-09-07
Koessinger and colleagues show that glioblastoma, including patient-derived stem-like cells, is unusually dependent on anti-apoptotic BCL-XL and MCL-1 for survival. The study links this apoptotic priming to therapeutic sensitivity and demonstrates that sequential inhibition of these proteins can produce strong preclinical antitumor responses.